Table 3.
Efficacy of combination regimens using fludarabine plus concurrent monoclonal antibodies in chronic lymphocytic leukemia (CLL) in Phase II trials.
View large
Efficacy of combination regimens using fludarabine plus concurrent monoclonal antibodies in chronic lymphocytic leukemia (CLL) in Phase II trials.

Abbreviations: CR, complete response; CYC, cyclophosphamide; FLU, fludarabine; PR, partial response.* Rituximab 375 mg/m2 course 1500 mg/m2 all subsequent courses.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal